Pulmonary Sarcomatoid Carcinoma

• CLINICAL_TRIALS trial_result · 2025-12-31
  Clinical Trial Update: Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma [Phase 2]

  Phase II study evaluating the combination of durvalumab, doxorubicin, and ifosfamide in pulmonary sarcomatoid carcinoma (a form of non-small…

• CLINICAL_TRIALS other · 2024-10-01
  Clinical Trial Update: Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma [Phase 2]

  A Phase 2 clinical trial update describes the use of camrelizumab plus famitinib in advanced or metastatic pulmonary sarcomatoid carcinoma, …

• CLINICAL_TRIALS trial_result · 2024-06-06
  Clinical Trial Update: Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma [Phase 2]

  Phase II clinical trial evaluating the combination of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma has completed.

• CLINICAL_TRIALS trial_result · 2024-05-29
  Clinical Trial Update: Pulmonary sarcomatoid_MEDI4736+Treme [Phase 2]

  A Phase 2 trial evaluating the combination of durvalumab and tremelimumab for pulmonary sarcomatoid carcinoma and non-small cell lung cancer…

• CLINICAL_TRIALS trial_result · 2021-04-06
  Clinical Trial Update: Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma [Phase 2]

  Phase 2 trial evaluating toripalimab with bevacizumab, nab-paclitaxel, and carboplatin for untreated metastatic pulmonary sarcomatoid carcin…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.